Literature DB >> 15463358

Mechanisms underlying immunosuppression induced by Trypanosoma cruzi.

F Kierszenbaum1, M B Sztein.   

Abstract

Trypansoma cruzi affects immune responsiveness in mammalian hosts. Studies with patients and infected animals have defined some of the immunological dysfunctions but not the underlying mechanisms. Recent work using an in vitro model system of T. cruzi-human lymphocyte interactions has made it possible to uncover specific alterations in human lymphocyte activation induced by this parasite. Felipe Kierzenbaum and Marcelo Sztein discuss recent advances in our understanding of the processes that lead to impaired human lymphocyte function and that might be involved in the immunosuppression seen in the acute phase of Chagas disease.

Entities:  

Year:  1990        PMID: 15463358     DOI: 10.1016/0169-4758(90)90187-9

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  6 in total

1.  Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.

Authors:  Romina P Muiá; Hai Yu; Jennifer A Prescher; Ulf Hellman; Xi Chen; Carolyn R Bertozzi; Oscar Campetella
Journal:  Glycobiology       Date:  2010-03-30       Impact factor: 4.313

2.  Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells.

Authors:  Pablo Ruiz Díaz; Juan Mucci; María Ana Meira; Yanina Bogliotti; Daniel Musikant; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2015-03-09       Impact factor: 3.441

3.  Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.

Authors:  A P Galvão da Silva; I de Almeida Abrahamsohn
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

Review 4.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

5.  A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.

Authors:  G Adam Mott; Jaime A Costales; Barbara A Burleigh
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

6.  A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.

Authors:  C Hernández-Munaín; J L De Diego; A Alcina; M Fresno
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.